Abstract
Oestrogen receptor (ER) is used routinely to predict endocrine responsiveness in patients with breast cancer. A second ER, ERβ has been described but its significance remains undefined; most studies have described mRNA levels rather than protein expression. Here, we demonstrate for the first time, immunohistochemical detection of ERβ in archival breast tumours. © 2001 Cancer Research Campaign.
Author supplied keywords
Cite
CITATION STYLE
Skliris, G. P., Carder, P. J., Lansdown, M. R. J., & Speirs, V. (2001). Immunohistochemical detection of ERβ in breast cancer: Towards more detailed receptor profiling? British Journal of Cancer, 84(8), 1095–1098. https://doi.org/10.1054/bjoc.2001.1721
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.